Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3182 of 6351
-
Could a common mood drug slow Parkinson's? early trial hints at possibility
Disease control CompletedThis study will examine the effects of lithium aspartate 30-45mg/day on MRI biomarkers and blood-based therapeutic targets among 15 early-stage Parkinson's disease patients.
Phase 1 • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Brain training for epilepsy: new hope for memory and mood
Symptom relief OngoingEpilepsy is a complex and chronic neurological disorder whose definition is not limited to seizures and also includes social, psychological, and cognitive consequences associated with this frequent condition. Despite good knowledge of the burden of cognitive deficits and psychoso…
Sponsor: Vilnius University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New cream shows promise for vulvar itch relief
Symptom relief CompletedThe purpose of this study is to explore the efficacy and safety of MC2-25 cream and MC2-25 vehicle in women with vulvar lichen schelosus (VLS).
Phase 2 • Sponsor: MC2 Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New hope for tough leukemia: drug combo targets hidden cancer cells
Disease control OngoingThis phase I trial tests the safety, side effects, and determination of the best dose of uproleselan in combination with fludarabine and cytarabine in treating patients with acute myeloid leukemia, myelodysplastic syndrome or mixed phenotype acute leukemia that has come back (rel…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New course aims to lift brain fog in Graves' patients
Symptom relief Recruiting nowBACKGROUND. Mental fatigue (MF) is common in the most common form of hyperthyroidism, Graves' disease (GD). Clinically, MF is the primary mental symptom in patients with GD and is characterized by difficulties maintaining attention, exhaustion during cognitively demanding tasks, …
Sponsor: Vastra Gotaland Region • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Could checking in on symptoms each session boost therapy outcomes?
Disease control OngoingAlthough measurement-based care (MBC) is an evidence-based practice with known benefits, it is not always systematically implemented with fidelity. Questions remain regarding MBC's unique added value compared to usual care. Thus, the goal of this clinical trial is to investigate…
Sponsor: Carilion Clinic • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New clinic aims to tackle weight gain in mental health patients
Disease control Recruiting nowThis study will examine the effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness
Sponsor: Bjorn H. Ebdrup • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Video games tested as therapy for swallowing problems after stroke
Symptom relief CompletedThe goal of this clinical trial is to investigate the effect of video-game on swallowing function in patients with dysphagia through a randomized controlled trial and whether it has additional benefits in improving swallowing function and training compliance compared with convent…
Sponsor: ZHANG Bohan • Aim: Symptom relief
Last updated Jun 26, 2026 16:57 UTC
-
Can stress tests reveal hidden heart damage in sickle cell patients?
Knowledge-focused Recruiting nowThere is limited information on what causes injury to the heart in individuals with Sickle Cell Disease (SCD). Researchers in this study want to see if decreased blood flow to the heart during stress could be causing the heart damage seen in SCD patients. They also want to test p…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New study tackles the hidden harm of weight stigma
Symptom relief Recruiting nowThis project proposes to integrate a psychosocial approach into the therapeutic patient education program (TPE) at "La Vie la Santé", an innovative health promotion platform at Poitiers University Hospital. A randomized study will be set up within the active file of patients refe…
Sponsor: Poitiers University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
AI learns to detect endometriosis in real time during surgery
Knowledge-focused CompletedDevelopment of AI-based approaches for automated real-time detection of endometriosis lesions using endoscopic image and video material.
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Lupus kidney drug for teens shows promise, but trial cut short
Disease control Stopped earlyThe purpose of this study is to assess the efficacy and safety of voclosporin compared to placebo in achieving renal response following 24 weeks of therapy in adolescent and pediatric subjects with active lupus nephritis (LN).
Phase 3 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
HIV drug dosing study aims to protect moms and babies
Disease control Recruiting nowA randomised, open label, controlled PK standard of care vs doravirine plus 2 nucleoside reverse transcriptase inhibitors backbone in pregnant women initiating combination antiretroviral therapy in the second trimester of pregnancy.
Phase 4 • Sponsor: University of Liverpool • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Lifestyle overhaul may ease chest pain in hidden heart disease
Disease control OngoingThe SAMCRO is an all comers, prospective, randomized, multicenter, open-label study with blinded adjudicated evaluation of outcomes (PROBE). The diagnosis of angina in non obstructive coronary artery disease (ANOCA) will be confirmed with coronary artery angiography and with the …
Sponsor: Consorzio Futuro in Ricerca • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a Heart-to-Heart talk keep dialysis patients on track?
Disease control OngoingMoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group r…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a sleep drug boost brain power in seniors?
Symptom relief CompletedThe goal of this study is to examine the impact of suvorexant, an FDA-approved insomnia medication, on daytime symptoms (as measured by the Daytime Insomnia Symptoms Scale: cognition, positive mood, negative mood, and fatigue/sleepiness) among older adults with insomnia. The prim…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Heart failure drug shows promise in rebuilding damaged hearts
Disease control CompletedThe biological process that underlies the pathogenesis of heart failure (HF) is termed cardiac remodeling. Pathological cardiac remodeling includes structural and functional change of the heart. Structural cardiac remodeling in HF include dilatation and/or hypertrophy of cardiac …
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New pill and immunotherapy combo tested for Hard-to-Treat cancers
Disease control OngoingThe main goal of this first in human (FIH) study is to learn about the safety and dosing of GS-9911 when given alone or in combination with an anti-programmed cell death protein 1 (PD-1) monoclonal antibody in participants with advanced solid tumors. The primary objectives of th…
Phase 1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New scan could reveal hidden heart attack triggers
Diagnosis Recruiting nowThe Primary Objective is to determine if a new nuclear tracer (named 18F-Florbetaben) used with nuclear imaging (PET imaging) can detect inflamed plaque in patients with recent ACS or stroke/TIA.
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
Fish oil shows promise for Tough-to-Treat asthma
Disease control CompletedAsthma is a syndrome compromising many phenotypes including N-ERD (caused by increased 4-series leukotriene (LT) production). n-3 PUFA supplementation modulates 4-series LT and has anti-inflammatory effects. However, other than in a pilot study with dietary manipulation, the effe…
Phase 3 • Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC